the Governance of Counterfeit Medicines: A Mapping Exercise… – a new paper
There is a new paper from JOURNAL OF HEALTH DIPLOMACY that is worth of taking the time to read. Just the impact to combating Global Health issues associated with and tangential to WASH efforts is huge, not to mention many other areas of global health. This 21 page paper does a great job of addressing / itemizing the complexities of a problem, that laymen would think could be solved in a fortnight.
Global Health Diplomacy and the Governance of Counterfeit Medicines: A Mapping Exercise of Institutional Approaches
By Tim K. Mackey*
AbstractObjective. Counterfeit medicines are a global, multi-faceted, and complex public health problem. Global health diplomacy and cooperative efforts relying on governance systems have been limited in effectively addressing proliferation of this dangerous trade. Methods. This review conducts a comprehensive mapping exercise of governance efforts by international organizations to address counterfeit medicines, including analysis of related international treaties and conventions that may be applicable to anti-counterfeit efforts. This work also reviews governance and global health diplomacy proposals from the literature that addresses counterfeit medicines.Summary of Findings. A number of international organizations have become active inaddressing the global trade of counterfeit medicines. However, governance approaches by international organizations, including the World Health Organization (WHO), the United Nations Office on Drugs and Crime (UNODC), Interpol and the World Customs Organization (WCO), have varied in scope and effectiveness. Treaty instruments with applicability to counterfeit medicines have also not been fully leveraged to combat this issue. Results indicate that a formalized and multi-stakeholder governance mechanism is needed to address the issue. The UNODC is uniquely situated to act as a forum for such a proposal in partnership with other international organizations.Implications of Findings. Global health diplomacy efforts to combat counterfeit medicines require multi-stakeholder and formalized governance structures that can leverage stakeholder participation and resources. Through cooperative arrangements leveraging the strengths of partners such as UNODC (combating transnational crime), Interpol (lawenforcement purposes), the WCO (customs and border control), and the WHO (for public health science and analysis), the international community can mobilize a coordinated, inclusionary, health diplomacy response to the crisis of global counterfeit medicines.
* Tim Mackey, MAS, is a Senior Research Associate with the Institute of Health Law Studies, California Western School of Law; a Ph.D. Candidate with the Joint Doctoral Program on Global Health, University of California San Diego-San Diego State University; an Investigator with the San Diego Center for Patient Safety, University of California San Diego School of Medicine; a Clinical Instructor (Health Services) with the Department of Anesthesiology, University of California San Diego School of Medicine; and the Coordinator for Global Health Research with the Joint Program on Health Policy, University of California, San Diego-California Western School of Law. He is a recipient of the 2012 Horowitz Foundation for Social Policy Grant for graduate researchers, the 2011-2012 Carl L. Alsberg, MD Fellow, Partnership for Safe Medicines and the Rita L. Atkinson Fellow, and gratefully acknowledges that support. E-mail: firstname.lastname@example.org
Citation: Mackey, T. (2013). Global Health Diplomacy and the Governance of Counterfeit Medicines: A Mapping Exercise of Institutional Approaches. Journal of Health Diplomacy. Published online June 13, 2013.
Editor: Rachel Irwin, Stockholm International Peace Research Institute
Managing Editor: Mark Pearcey, Carleton University
Published: June 13, 2013
Type: Review Article – Peer Reviewed
Journal of Health Diplomacy:
The Journal of Health Diplomacy (JHD) is an open-access, peer-review journal that publishes editorials, original research papers and commentaries on issues pertaining to the field of health diplomacy. In keeping with its objective – of generating and disseminating research to ensure foreign policy decisions and discourses on global health are informed by the best available evidence – issues are published twice annually on a thematic basis; themes are selected based on their timeliness and relevance to the field. JHD welcomes contributions from all academic disciplines, including anthropology, geography, history, international relations, legal studies, political science and sociology.
- Africa: 550 million counterfeit medicine seized in 10 days (custom-ised.com)
- The World Customs Organization (WCO) and the Institute of Research Against Counterfeit Medicines (IRACM) issue a new warning about the health and safety of African populations (nlipw.com)
- Firm hopes end to fake drugs is on Horizon (independent.ie)